REG - Hikma Pharmaceutical - Director/PDMR Shareholding <Origin Href="QuoteRef">HIK.L</Origin>

Hikma PharmaceuticalsAnnouncement

08/02/2018 12:45

RNS Number : 3431E
Hikma Pharmaceuticals Plc
08 February 2018
Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Said Darwazah
2
Reason for the notification
a)
Position/status
Chairman and Chief Executive Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Pledge by Darhold Limited by 6,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Morgan Stanley Bank, N.A. The Chairman and Chief Executive is a director of and shareholder in Darhold Limited with an equity interest of 21.67%.
c)
Price(s) and volume(s)
Price(s): 0.00p
Volume(s): 6,000,000
d)
Aggregated information
Aggregated volume: 6,000,000
Price: 0.00p
e)
Date of the transaction
7 December 2017
f)
Place of the transaction
Amman
Mazen Darwazah
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mazen Darwazah
2
Reason for the notification
a)
Position/status
Executive Vice Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Pledge by Darhold Limited by 6,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Morgan Stanley Bank, N.A. The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 10.92%.
c)
Price(s) and volume(s)
Price(s): 0.00p
Volume(s): 6,000,000
d)
Aggregated information
Aggregated volume: 6,000,000
Price: 0.00p
e)
Date of the transaction
7 December 2017
f)
Place of the transaction
Amman
Mohammed 'Ali' Al-Husry
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mohammed 'Ali' Al-Husry
2
Reason for the notification
a)
Position/status
Non-Executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Pledge by Darhold Limited by 6,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Morgan Stanley Bank, N.A. The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.01%.
c)
Price(s) and volume(s)
Price(s): 0.00p
Volume(s): 6,000,000
d)
Aggregated information
Aggregated volume: 6,000,000
Price: 0.00p
e)
Date of the transaction
7 December 2017
f)
Place of the transaction
Amman

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHBDGDDGSGBGII